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Abstract	  
Genital human papillomavirus infection is the most common sexually transmitted virus in the 
United States, with almost 20 million Americans currently infected and an additional 6.2 million 
becoming newly infected each year. Women rely strongly on their health care providers to 
educate and comfort them regarding this distressing diagnosis. This study will use an online, self-
completion questionnaire to obtain women’s opinions regarding their health care providers’ 
performances concerning the initial consultation after learning of their HPV diagnosis. Findings 
from this study provided insight as to how women prefer receiving information from their health 
care providers concerning their diagnosis of HPV. In addition, study findings provide suggestions 
for improving clinical practices regarding HPV consultations in the Tri-cities area of East 
Tennessee.  
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Background	  
Each year millions of women worldwide go to their health care providers and learn they 
are infected with a sexually transmitted disease. The most prevalent viral diagnosis relates to a 
relatively new virus called human papillomavirus, commonly referred to as HPV. Genital human 
papillomavirus infection is the most common sexually transmitted virus in the United States, with 
almost 20 million Americans currently infected and an additional 6.2 million becoming newly 
infected each year (Friedman & Shepeard, 2007). HPV is diagnosed through cytological 
examination as enlarged cervical cells with a clear zone around the nucleus, but most women see 
it in the form of abnormal Papanicolaou (Pap) smear results.  
Discovered in 1976, the Human Papillomavirus is a new addition to the long list of 
universally accepted sexually transmitted infections. Since its initial discovery, over 100 strands 
of the small, circular, double-stranded, non-enveloped deoxyribonucleic acid tumor virus have 
been classified (Gelman, Nikolajski, Schwarz, & Borrero, 2011). The HPV DNA incorporates 
itself into the target cell genome, activates oncogenes then proceeds to suppress the host cell’s 
immune response. HPV protein products prevent cells from causing programmed cell death, 
which leads to instability and unchecked cell growth (Fey & Beal, 2004). 
Each of the different HPV strands have the capability to cause low-grade cell changes in 
the cervix, but there are several that are more notable because of their tendency to cause high-
grade cell abnormalities. “Low-risk” genotypes can cause benign or low-grade cervical tissue 
changes and genital warts. There is an international consensus that “high-risk” genotypes, 
including strands 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 66, can eventually lead to 
cervical cancer and have been associated with other cancers of the head and throat. Of the 100+ 
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HPV genotypes, there have been eight that frequently reoccur the most worldwide: 16, 18, 31, 51, 
52, 53, 56, and 58 (Cutts, Franceschi, Castellsague, Sanjose, & Garnett, 2007). In 2006, the U.S. 
Food and Drug Administration approved a quadrivalent vaccine that protects against strands 16, 
18, 6, and 11—the culprits responsible for 70% of cervical cancer and 90% of genital warts. The 
vaccine has since been recommended by the Advisory Committee on Immunization Practices for 
use in females aged 9 to 26 years (Friedman & Shepeard, 2007).   
Prevalence of HPV, is highest in young, sexually active women 18 to 25 years of age (Fey 
& Beal, 2004). The human papillomavirus is primarily transmitted by genital skin-to-skin contact, 
usually but not necessarily during sexual intercourse. Risk of HPV infection is directly linked to 
the number of sexual partners that a woman has had recently and throughout the span of her life 
(Cutts, Franceschi, Castellsague, Sanjose, & Garnett, 2007). Those who receive the vaccine 
before the beginning sexual intercourse have a decreased risk of getting HPV, but are not 
completely immune to all forms of the virus. Women who do become infected with HPV can 
have high survival rates with routine tests and appropriate follow-up.  
In truth, the human papillomavirus is a relatively new sexually transmitted disease and as 
such there has been little information published regarding the psychosocial effects of being 
diagnosed with HPV. It is vital that health care providers spend time educating women about 
HPV prevention and thoroughly discussing the proposed plan of care following diagnosis. before 
they get it and thoroughly discussing it with those who have already become infected. It is 
estimated that as many as 80% of sexually active women will be positive for HPV at some point 
in their lives and health care providers need to be mindful that a large portion of those women are 
utterly unaware about what HPV is. (Akyuz, Yilmaz, Yenen, Yavan, & Kilic, 2011) Although 
health care providers may recognize that generally only one-fifth of all untreated human 
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papillomavirus-associated lesions will lead to cervical cancer, the women just discovering that 
they have a sexually transmitted disease will not (Fey & Beal, 2004). Ultimately, even with the all 
of the precautionary care and treatments available, the biggest factors in preventing any adverse 
outcomes from HPV are the health care providers caring for those at risk. 
Overview	  of	  the	  Study	  
Genital human papillomavirus is the most common sexually transmitted virus in the United States 
with the rates becoming higher and higher each year. Women strongly rely on their health care 
providers to educate and comfort them regarding this distressing diagnosis. This study will be 
completed through a series of open-ended online questions, conducted anonymously, to obtain 
infected women’s perceptions of their healthcare provider’s performance concerning the initial 
consultation after receiving the news of their HPV diagnosis. Questions asked in the survey will 
focus on exposing deficiencies in the health care consultation and inquire as to changes women 
would have liked regarding their HPV diagnosis. The results of this study will offer insight in to 
what women would appreciate hearing from their health care providers concerning their diagnosis 
and therefore possibly improve clinical practices regarding HPV in the Tri-Cities area of East 
Tennessee.  
Objectives	  
  The objective of this study is to determine, through an online survey, whether 
women infected with the human papillomavirus are satisfied with their health care consultation 
subsequent to their initial diagnosis. Questions in the survey focus specifically on obtaining 
personal accounts from women concerning the first meeting with their health care provider 
regarding their HPV diagnosis. The information obtained in this study should illuminate how 
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deeply women’s lives are affected by this sexually transmitted infection and also how effectively 
clinicians are addressing the psychosocial aspect of the diagnosis.  
Hypothesis	  
	   Health care providers play a detrimental role in providing and promoting health education 
to their patients. In addition, health care providers are privy to intimate details of patients’ lives, 
especially when dealing with the sensitive topic of sexually transmitted infections. Health care 
providers who act as both an educator and a confidant are more likely to have an impact on their 
patients than those who simply educate. Women diagnosed with HPV whose health care 
providers gave thorough explanations about the virus and addressed the impact the diagnosis will 
have on future sexual relationships will be more comfortable with HPV than those whose health 
care providers did not.  
Literature	  Review 
The literature on the human papillomavirus is rather abundant for a disease discovered less 
than fifty years ago. The largest dilemma concerning the availability of the literature is, because 
HPV is a relatively new virus, the information is constantly being updated and older studies are 
being proven completely incorrect or erroneous. A plethora of articles have been published about 
the biological structure of HPV and how it affects the cervical cells of those who become 
infected. The American Family Physician journal has had several articles that contain very 
thorough explanations of what HPV is and does to the female body.  FT Cutts, et al, (2007) 
published an article in the Bulletin of the World Health Organization about human papillomavirus 
and the current vaccines approved for its prevention. In the article they discuss the numerous 
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different strands of HPV and the methods by which the vaccines help protect the human body 
against them.  
Newer studies are now beginning to tackle the issue of public knowledge and perceptions 
of the human papillomavirus. A study done in 2006 by Allison L. Friedman and Hilda Shepeard 
focused on obtaining the level of knowledge about HPV and the opinions associated with it. They 
used 315 participants separated into 35 focus groups to develop a set of thematic results which 
summarized the overall opinions of each group. Categories of questions ranged from knowledge 
about epidemiology to STD-associated stigmas regarding HPV. Their study found that most of 
the participants had heard about STD related genital warts and were able to explain that most 
STDs are treatable. However, there were large misconceptions that men are affected by genital 
warts more frequently and that all forms of genital warts are related to herpes. Overall, the study 
found there was low HPV awareness across all of the groups and in general only one or two 
people from each group had ever heard of the virus.  
A more recent study utilized a couple of outpatient gynecology clinics in Turkey to obtain 
information about women’s overall awareness of the human papillomavirus (Akyuz, Yilmaz, 
Yenen, Yavan, & Kilic, 2011). Using a multiple-choice questionnaire, the study surveyed a total 
of 229 Turkish women about their knowledge and attitudes towards the vaccines, tests, and the 
virus itself. After analysis, this study showed that although most women were aware of HPV, 
most did not know that it is a sexually transmitted. From this study the authors concluded that 
even women positive for HPV have insufficient knowledge about the virus and the health risks 
associated with it. 	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Catherine Cook, a researcher at the University of Auckland in New Zealand, conducted in-
depth research on the psychosocial effects of the human papillomavirus and other sexually 
transmitted infections.  In 2009 she published her doctoral thesis that analyzed a series of 
interviews she conducted via email in 2007, which were used to gauge the opinions of women 
diagnosed with HPV and other viral STIs about their clinical experiences. Through her qualitative 
research she found that although many clinicians are able to de-sexualize gynecological 
examinations and view the cases as purely “objective,” many patients cannot. She found that 
women often view clinical consultations regarding sexually transmitted diseases as more taboo 
than other conditions and thus perceive them as a “moral burden.” The research found that if 
health care providers followed an objective and routine protocol for their examinations, women 
would not risk asking anything inappropriate:  
“For many women patients, to ask a question that falls outside the parameters of the 
appropriate knowledge-base already established by the clinician is to risk being 
constituted as morally questionable, as a ‘risky’ woman rather than a ‘normal’ woman. To 
ask a question tells the Confessor something about one’s ‘true nature.’” (Cook, The 
Pedagogy of the Clinic: Health Professionals and Women with Viral Sexually Transmitted 
Infections, 2009, p. 131) 
Overall, the thesis concluded that health care providers should initiate questions about the 
diagnosis and female sexuality with each patient, especially if they have been diagnosed with a 
sexually transmitted infection.  
 In her follow up study, Catherine Cook further examined the email interviews she 
conducted in 2007. Through literary analysis she determined that the majority of medical research 
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focuses on female anxiety regarding the examination, but rarely does research focus on the 
influence of the health care providers’ practices in adding to the apprehension. During her 
thematic analysis of the qualitative data she identified that women are more likely to perceive the 
“normal” gynecological examination differently and become more vulnerable subsequent to 
learning of their sexually transmitted infection diagnosis. She concluded that when clinicians put 
an emphasis on “normalizing” somewhat uncomfortable medical procedures they ultimately 
discourage women from participating in vital follow up testing.  
Methods 
Population	  and	  Sample	  
 To obtain the most authentic results, only female individuals over the age of 18 who have 
been formally diagnosed with human papillomavirus were included in this study. Women must 
have had their initial post-diagnosis consultation in the Tri-Cities area of East Tennessee to be 
included in the qualitative portion of the survey. Recruitment for the study consisted of flyers 
placed in various locations throughout the Tri-Cities area of East Tennessee such as Health 
Departments, gynecology offices, public libraries, and campus health centers. An email was also 
distributed to all students of East Tennessee State University, which contained information and a 
link to the online survey. Any individual who expressed a desire to participate and meets the 
inclusion criteria is eligible to participate in the study. 
Instruments	  
 The instrument used for this study will be a self-completion questionnaire consisting of 
two parts. The first part of the survey will include demographic data used for statistical purposes 
only. These questions will be asked in a closed question format with a predetermined set of 
responses to choose from. Questions will inquire about gender, age, geographical area, time since 
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HPV diagnosis, and number of health care providers consulted about the HPV diagnosis. The 
second portion of the survey will include several questions taken from the study performed in 
2009 by Catherine Cook. These questions were deemed as being highly appropriate for use in this 
study and delivered thorough and in-depth responses from participants in the first study. These 
questions will be open format questions in which respondents will be able to voice their detailed 
and factual recollections. 
Data	  Collection	  
 In order to ensure the comfort and confidentiality of the participants, the research study 
was conducted entirely online. Utilizing SurveyMonkey.com to administer the survey questions 
ensured that each of the participants were able to remain anonymous, which allowed individuals 
to speak more freely if they wished to. SurveyMonkey.com creates a secure web link with Secure 
Sockets Layer encryption. The SSL encryption creates a cryptographic system that secures a 
connection between a client and a server. By using this website there was absolutely no way to 
trace information back to a specific server. SurveyMonkey.com reduced the risk of inflicting 
psychological harm that could have been sustained from feeling pressured or forced into 
discussing intimate information from face-to-face interviews.  
 The consent process began as soon as the participant visited the survey URL. The first 
“question” of the survey served as an electronic consent form. In-depth information about the 
survey was provided and the participant was asked if they still wished to continue forward with 
the anonymous online survey. If the participant selected that they did not wish to participate, they 
were re-directed to a page thanking them for taking the time to read about the study and that they 
would be asked no further questions. If the participants selected that they were interested in 
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continuing with the study, they were immediately advanced to the demographic portion of the 
survey.  
 Once the participants agreed to participate in the study they were directed through a series 
of online questions. The first four questions of the survey acted as a demographic, 
inclusion/exclusion assessment. If the participant was not eligible to answer the qualitative 
questions, he or she would be re-directed to a conclusion page thanking them for their time. If the 
participants were eligible, they would proceed to the focused HPV portion of the survey. These 
questions were both open and close ended; inquiring in to the health care experience they received 
regarding their HPV diagnosis. If any of the questions made the participant feel uncomfortable 
they were allowed to omit the question and continue with another question. After they completed 
the survey they were re-directed to a completion page, which thanked them for their participation 
and informed them that there were no more questions.  
Data	  Analysis	  
 Data analysis for this study consisted of both statistical and thematic review of the 
collected data. Quantitative survey responses were entered into an Excel spreadsheet for grouping 
purposes.  Data was checked for input errors and corrected.  IBM Statistical Product and Service 
Solutions (SPSS) version 20.0 was used to analyze the data after being transferred from the Excel 
spreadsheet.	  The qualitative data was analyzed thematically under the standards developed by 
Braun and Clarke. Under these standards, the information from the study was reviewed in six 
distinct steps: familiarization with the data collected; generating initial codes; searching for 
themes; reviewing themes; defining and naming themes; and then the production of the report. 
Both a qualitative data analysis expert and a women’s health specialist reviewed the material to 
ensure the relevancy and validity of the results. The thematic analysis examined and pinpointed 
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trends in the data collected; this form of analysis was useful in producing a compilation of topics 
that needed to be addressed by health care providers.  
Results	  
Qualitative	  Responses	  
 On the survey conclusion date of October 11th, 2013, a total of 233 individuals had taken 
the online survey regarding HPV. To ensure validity of the qualitative responses receieved, each 
of the demographic questions doubled as inclusion/exlcusion criteria for individuals such as those 
who were male, had not been diagnosed with the human papillomavirus, or had been diagnosed 
outside of the Tri-Cities area of East Tennessee. SurveyMonkey was instructed to automatically 
exclude individuals who did not meet these criterion for the suvery, as well as participants who 
opted out of answering the demographic questions. 
Table 1. Consent 
Women with HPV and your Healthcare Experiences 
Do you consent to part icipate in this study? 
Answer Options 
Response 
Percent 
Response 
Count 
Yes 88.0% 205 
No 12.0% 28 
Answered question 233 
Skipped question 0 
Missing 0 
Total 233 
 The initial question in the survey was an electronic consent. Individuals who responded 
that they did not consent, 28 participants (12%), did not progress through the rest of the survey 
and were included in the overall “missing” total for Table 2 and the remainder of the results.  
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Table 2. Gender 
What is your gender? 
Answer Options 
Response 
Percent 
Response 
Count 
Female 91.6% 186 
Male 8.4% 17 
Answered question 203 
Skipped question 2 
Missing 28 
Total 233 
 The first actual question of the survey inquired as to the gender of the participant taking 
the survey. The 17 individuals (8.4%) who answered “Male,” as well as the 2 individuals who 
skipped the question, were not allowed to progress through the survey and were therefore 
included in the “missing” total for Table 3 and the remainder of the results.  
Table 3. HPV Diagnosis 
Have you ever been diagnosed with Human Papil lomavirus (HPV)? 
Answer Options 
Response 
Percent 
Response 
Count 
Yes 35.1% 65 
No 64.9% 120 
Answered question 185 
Skipped question 1 
Missing 47 
Total 233 
 Of the females who consented to take the survey, 35.1% (65 participants) had been 
diagnosed with the human papillomavirus. One individual opted to leave the question blank and 
was therefore included in the “missing” total, as were the 120 participants without HPV.  
Table 4. Age 
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Which category below includes your age? 
Answer Options 
Response 
Percent 
Response 
Count 
17 or younger 0.0% 0 
18-20 7.7% 5 
21-23 20.0% 13 
24-26 26.2% 17 
27-29 9.2% 6 
30-40 29.2% 19 
40 or older 7.7% 5 
Answered question 65 
Skipped question 0 
Missing 168 
Total 233 
 Of the 65 individuals diagnosed with HPV, all 65 reported an age. Although women under 
the age of 18 who are diagnosed with HPV were relevant to this study, they were to be excluded. 
The 5 females over the age of 40 diagnosed with HPV (7.7% of those who responded) were also 
excluded from taking the qualitative portion of the survey and were included in the overall 
“missing” total.  
Table 5. Location of Diagnosis 
Answer Options 
Response 
Percent 
Response 
Count 
Bristol, TN 8.5% 5 
Bristol, VA 1.7% 1 
Elizabethton, TN 1.7% 1 
Johnson City, TN 28.8% 17 
Kingsport, TN 6.8% 4 
Outside of East Tennessee 52.5% 31 
Answered question 59 
Skipped question 1 
Missing 173 
Total 233 
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 In the last exclusion eligible question, participants were asked the location of their initial 
HPV diagnosis. Individuals were given five cities classified as being within the “Tri-Cities” area 
of East Tennessee and Southeast Virginia. The 31 participants (52.5%) of females diagnosed with 
HPV outside of East Tennessee were ineligible to take the qualitative portion of the survey.  
Table 6. Healthcare Providers & Impact 
How big an impact have you found doctors and nurses to have on your overal l  
experiences to date l iv ing with HPV? 
Answer Options 
Response 
Percent 
Response 
Count 
Big impact 4.5% 1 
Some impact 36.4% 8 
No opinion 27.3% 6 
Little impact 18.2% 4 
No impact 13.6% 3 
Answered question 22 
Skipped question 6 
Missing 205 
Total 233 
 The very last question of the survey was also a quantitative question, which asked 
participants how big of an impact they felt their health care providers had on their overall 
experiences of living with HPV. This question was answered by 22 of the 28 eligible participants, 
8 of which (36.4%) stated that their healthcare providers had some impact on their experience.  
Qualitative	  Findings	  
 The qualitative portion of the survey allowed for the participants to voice their thoughts 
anonymously and truthfully. Participants were asked a series of seven open-ended questions that 
sought in-depth descriptions of their experiences with healthcare professionals and their feelings 
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regarding their diagnosis. Several trends appeared throughout the responses that can be 
categorized by one major theme.  
Unmet	  Client	  Needs	  
	  	   Based on the responses provided through the online SurveyMonkey survey, it was 
apparent that the main theme was ‘unmet client needs.’ Two distinct subthemes also emerged in 
the process of analyzing data, which are explained in detail later in this section.  
Figure 1. Theme Analysis 
	  
Figure 1 is a visual interpretation of the theme and the two subthemes developed through the 
responses given for the qualitative portion of the survey. With the major theme being, ‘Meeting 
Client Needs,’ the quotes show trends in the responses that were provided which link to both of 
the subthemes, ‘Unanswered Questions’ and ‘Individualized Needs.’ 
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Unanswered	  Questions	  
	   A number of respondents found that their diagnosis of human papillomavirus left them 
“nervous,” “frightened,” and “shaken up.” These women most often stated that they were notified 
of their diagnosis via a letter sent in the mail informing them of their “abnormal” Papanicolaou 
test results. The women that did receive phone calls from their gynecology office spoke to an 
uninformed office staff member rather than their actual healthcare provider. One of the 
individuals stated:  
 When the office staff member called me she was unable to answer any of my questions about 
HPV. I was frustrated. I called back to ask more questions, but the staff member was unable 
to answer anything. I was told to come back in three months. I then called my friend who’s a 
women’s health nurse practitioner to get information.  
Following suit, another participant who had the same experience suggested that only health care 
professionals make phone calls to patients because the office secretaries add to the stress of the 
new diagnosis. 
 I would also encourage health professionals to not have staff members that can’t answer 
questions call patients with results. I was scared and freaked out by the diagnosis and the 
person on the phone couldn’t give me any information about what that meant or how it 
would be treated.  
Some of the women who received the letter in the mail attempted to contact their clinician in an 
attempt to learn more about their diagnosis but felt were poorly treated for doing so.   
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 After getting the letter in the mail I had to get into contact with my gynecologist to learn 
more about what the lab results meant. She did not call me back for a couple of days and 
then she was very short with me when I asked questions about it.  
The theme of unanswered questions does not end with the initial diagnosis. Women in the 
survey reported that they still felt uneducated about their diagnosis months after they had 
received their abnormal results. Some women were even unsure of how exactly they were 
diagnosed with HPV: 
For me, no one had told me about HPV when I was having the pap test done. I still to 
this day do not know if you can find out if you have HPV through a pap test or if it has 
to be a specific test for HPV. 
 In addition to medical questions, most respondents had unanswered questions regarding 
their sexual relationships. Women in the study were often seeking answers about their 
relationships that could not be directly answered by laboratory results or a medical consultation. 
Information pertaining to relationship fidelity and sexuality were identified by many of the 
participants as topics health care providers should address in the initial consultation. One woman 
stated:  
 I think it is difficult to ask questions regarding the length of time I’ll have the STD and 
also about what it means for my current/future sexual partners.  
The concern for contamination of others was reiterated throughout the open-ended responses as a 
topic that needed to be discussed by health care providers in the initial consultation for the new 
HPV diagnosis. Another participant was worried about what it would mean for her current 
relationship as well:  
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It’s hard to ask about spreading the disease because once you know you have a 
responsibility to be careful and tell your partner, which was really hard for me since I had 
just started dating the man of my dreams. 
These responses from the study reiterate that a new diagnosis of human papillomavirus is stressful 
and can leave the patient extremely worried. In addition, most participants felt that they were not 
receiving adequate information regarding their diagnosis nor were they receiving any empathy 
from their health care providers regarding their situation.  
Individualized	  Needs	  	  
 The second theme that was apparent from the collected data was the difference of the 
needs of each woman in the study. The new diagnosis of HPV combined with numerous other life 
stressors leaves these individuals vulnerable and confused. Women in the study all sought 
different things from their health care provider and the only commonality between these needs 
was that none of them were met. In the responses some women stated that they wanted their 
health care provider to tell them “everything they know about HPV and be straight forward,” 
whereas others felt that a good majority of the information was irrelevant. One participant stated: 
 There are way too many scare tactics out there with HPV. I would want a health 
professional to discuss how common it is and how it typically clears on its own.  
Other women also supported the assumption that health care professionals try to use “scare 
tactics” to coerce women into agreeing to do unnecessary procedures regarding their diagnosis.  
 The health department makes you think you have cancer when they inform you that you 
have HPV. I don’t think they should scare us into thinking we need unnecessary 
procedures for mild dysplasia.  
Defayette	  
Health	  Care	  Providers	  and	  HPV	  
21	  
	  
Yet other participants were disappointed that they weren’t given more education or support 
regarding their diagnosis. They felt their health care professionals were unfeeling of their 
situation. One participant was extremely affected by the perceived insensitivity of her health care 
provider, writing: 
 I sat there feeling gross and helpless while the doctor seemed not to care. I was crying and 
she made me feel like complete shit by her attitude. I had so many questions that she did 
not answer. Granted, I did not ask many questions at the time because I was still shocked 
to learn I had an STD. I had recently been sexually assaulted by two different guys at a 
party and was feeling the anger and hurt all over again. While I don’t remember if she 
knew this information, I really needed some emotional support and she seemed overall 
unfazed by my diagnosis. She had me go ahead and get the Gardasil shots and prescribed 
me a cream to get rid of the warts.  
Although this situation was not the norm for most of the participants, other women were also 
affected by the perceived lack of empathy given by their health care providers. One participant 
was so deeply affected by the attitude of her healthcare provider she chose to go to someone else: 
 My first experience was very different than anything else in that I felt so lost and confused 
while the doctor acted like she saw this all the time and it was nothing new to her. She was 
so cold about the whole thing; I immediately switched to a different doctor.  
Another participant was upset because, although she knew that her healthcare provider frequently 
saw HPV patients, she felt the conversation was not what she needed it to be. She stated,  
I felt that my doctor was too casual about the conversation, perhaps because of his 
experience in seeing these infections clear on their own.  
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When asked about what ‘prescription’ participants would give health professionals about and 
ideal consultation process in relation to a new human papilloma diagnosis one participant wrote,  
 I think you have to be compassionate. Just because this is an STD that most people have 
(men just don’t know it) doesn’t change how it makes you feel. Plus they may not know 
each woman’s circumstances.  
The majority of participants in this study believed that their health care providers were 
uninformed of their needs and thus were unable to connect with them emotionally. A few 
participants thought highly of their health care providers because they were “comforting” and 
treated them “with great professionalism and respect.”  
Discussion	  
 Although there were several positive comments about the experience of the initial human 
papillomavirus consultation, for the most part these responses illuminate that there is a large 
psychosocial component of the consultation that is being neglected by women’s health providers. 
Due to the sensitive nature of the topic, women often felt as if they were completely alone in 
coping with their new diagnosis and their healthcare providers completely avoided the 
opportunity to act as a confidant. Most often these women were dealing with numerous issues 
separate from the diagnosis, which added to the stress of learning they had a sexually transmitted 
disease. Some women were frustrated, even angry, with their healthcare providers for not being 
more thorough with explanations and acting nonchalant about the effect this would have on their 
wellbeing. 
 In general, this study is rather unlike the majority of most literature available at this point 
in time. Whereas other studies sought to learn more about the overall knowledge and perception 
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of the human papillomavirus, very few have tackled the psychosocial component of the virus. The 
2009 study done by Catherine Cook titled, "The Pedagogy of the Clinic: Health Professionals and 
Women with Viral Sexually Transmitted Infections,” focused mainly on genital herpes but sought 
the same type of information. She found that although clinicans most commonly adopt a 
“nonjudgemental, sex positive approach” to the consultation, women felt unable to seek 
additional help. Her conclusion is similar to the interpretations made in this study regarding the 
unmet client needs. Women feel that by having a clinican use the minimalistic method when 
addressing the human papillomavirus they are not getting all the answers they need concerning 
the diagnosis nor are they receiving adequate emotional support.  
Implications	  for	  Nursing	  Practice	  
  Nurses working with women newly diagnosed with the human papillomavirus should be 
thoroughly educated on the topic and its progression. Based on the findings in this study, most of 
the women who were frustrated with their clinical experiences were disappointed by their 
inability to learn more about their diagnosis. Health care providers should experiment with 
addressing both the medical ‘normalcy’ of the human papillomavirus while also discussing the 
potential for these infections to disrupt women’s personal, sexual and social relationships. The 
current practice of discrediting the stigma of HPV on scientific grounds does not translate 
smoothly for women or transform their view.  
  Also based on the responses in this study, it seems appropriate for health care providers to 
initiate questions about the effects of the diagnosis upon women’s lives, especially addressing the 
impact upon both current and future sexual relationships. These questions indicate to the patient 
that the healthcare provider is okay with talking about HPV and open to all sexual habits. This 
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recommendation does not mean that health care providers need to become ‘sex therapists.’ It 
would be acceptable to ask simple questions, such as, “have there been any changes within your 
sexual relationships since you’ve been diagnosed with HPV?” which may then guide clinicians in 
the incorporate of medical ‘facts’ where they specifically relate to each individual’s 
circumstances.  
  It would also be helpful for healthcare providers to offer materials regarding the human 
papillomavirus prior to the initial consultation. The women in the study most frequently learned 
of their diagnosis via a letter in the mail, which was then followed by a call from a receptionist or 
office nurse who was unable to answer any case specific questions. While it would be preferable 
for the diagnosing provider to individually call each of his or her clients newly diagnosed with 
HPV, this is highly unrealistic due to the volume of work healthcare providers are assigned. 
Instead, it may be helpful to mail several informational brochures or a list of websites in which 
the individual can independently learn about her or his diagnosis. It is useful for healthcare 
providers to demonstrate knowledge of internet resources and to recommend specific websites. 
Women will use the internet regardless of what they are told via the phone or a consultation, so 
showing an awareness will more likely enable women to disclose internet use to clinicians.  
Limitations	  
 
There are a number of limitations present in this study, which may provide direction for 
future research studies. It may have been useful for the purposes of this study to interview 
healthcare providers in addition to the individuals diagnosed with HPV in order to receive a more 
balanced perspective on the initial consultation. It would have also been relevant to have used a 
different form of communication to receive the responses, because although the internet can allow 
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for more open communication it would have been theoretically better to perform interviews via 
email.   
The largest limitation of this study is that it is not necessarily generalizable to other areas 
outside of East Tennessee and Southeast Virginia. Due to the exclusion of those diagnosed 
outside of this area the results are only applicable to healthcare providers in this area. A larger 
study that examines a wider variety of ethnic, religious, and cultural backgrounds would be 
beneficial in confirming or disproving the results found through this study.  
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Survey	  Questions	  
1. Gender 
a. Female 
b. Male 
2. Have you ever been diagnosed with Human Papillomavirus (HPV)? 
a. Yes 
b. No 
3. Which category below includes your age? 
a. 18 – 20 
b. 21 – 23 
c. 24 – 26 
d. 27 – 29 
e. 30 – 40 
f. 40 or older  
4. In what area were you living when you learned of your HPV diagnosis? 
a. Bristol, TN 
b. Bristol, VA 
c. Elizabethton, TN 
d. Johnson City, TN 
e. Kingsport, TN 
f. Outside of East Tennessee 
5. Can you tell me about when and how you came to find out about your HPV diagnosis? 
6. What do you recall about the initial process of consulting a health professional about your 
diagnosis of HPV? 
7. How similar or different was the HPV consultation process compared to experiences 
consulting health professionals about other conditions? 
8. What questions, if any, are difficult to ask health professionals about HPV? Why? 
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9. Are there any topics you would find helpful for a health professional to initiate in a 
conversation related to HPV that would make you more comfortable? 
10. Based on your experiences, what is the ‘prescription’ you would like to give health 
professionals about an ideal consultation process in relation to women with HPV? What 
would you want for them to change about the whole process? 
11. Have health professionals ever initiated a conversation with you about the possible effects 
of living with HPV (both the physical and emotional impact) on sexual relationships? 
12. How big an impact have you found doctors and nurses to have on your overall experiences 
to date living with HPV?  
a. Big Impact 
b. Some Impact 
c. No opinion 
d. Little Impact 
e. No Impact 
 
 
 
Defayette	  
Health	  Care	  Providers	  and	  HPV	  
29	  
	  
 
 
 
 
East Tennessee State University 
Office for the Protection of Human Research Subjects x Box 70565 x Johnson City, Tennessee 37614-1707  
Phone: (423) 439-6053 Fax: (423) 439-6060 
 
 
 
 
Accredited Since December 2005 
IRB APPROVAL – Initial Exempt 
 
April 18, 2013 
 
 Danielle Defayette  
 
 
RE: Surveys of Women with HPV and their Healthcare Experiences 
IRB#: 0313.22s 
ORSPA#: , 
 
On April 18, 2013, an exempt approval was granted in accordance with 45 CFR 46. 
101(b)(2). It is understood this project will be conducted in full accordance with all 
applicable sections of the IRB Policies. No continuing review is required. The exempt 
approval will be reported to the convened board on the next agenda. 
 
x New Protocol Submission form, Bibliography, CV, Women's Participant 
Information Sheet, Flyer, Questionnaire 
 
 
Projects involving Mountain States Health Alliance must also be approved by 
MSHA following IRB approval prior to initiating the study. 
 
Unanticipated Problems Involving Risks to Subjects or Others must be reported to the 
IRB (and VA R&D if applicable) within 10 working days. 
 
Proposed changes in approved research cannot be initiated without IRB review and 
approval. The only exception to this rule is that a change can be made prior to IRB 
approval when necessary to eliminate apparent immediate hazards to the research 
subjects [21 CFR 56.108 (a)(4)].  In such a case, the IRB must be promptly informed of 
the change following its implementation (within 10 working days) on Form 109 
(www.etsu.edu/irb).  The IRB will review the change to determine that it is consistent 
with  ensuring  the  subject’s  continued  welfare. 
 
Sincerely, 
George Youngberg, M.D., Chair 
ETSU/VA Medical IRB   
Defayette	  
Health	  Care	  Providers	  and	  HPV	  
30	  
	  
 
 
 Accredited Since December 2005 
 
 
 
 
 
East Tennessee State University 
Office for the Protection of Human Research Subjects x Box 70565 x Johnson City, Tennessee 37614-1707  
Phone: (423) 439-6053 Fax: (423) 439-6060 
 
IRB APPROVAL – Minor Modification 
   
 
August 22, 2013 
 
 Danielle Defayette  
 
 
RE: Surveys of Women with HPV and their Healthcare Experiences 
IRB #: 0313.22s 
 
On 08/22/2013, a final approval was granted for the minor modification listed below.  The minor 
modification will be reported to the convened board on the next agenda. 
 
x Modification request to use East Tennessee State University's Office of the Provost to send out 
an "all-student" email to all students 
 
Unanticipated Problems Involving Risks to Subjects or Others must be reported to the IRB (and VA 
R&D if applicable) within 10 working days. 
 
Proposed changes in approved research cannot be initiated without IRB review and approval. The 
only exception to this rule is that a change can be made prior to IRB approval when necessary to 
eliminate apparent immediate hazards to the research subjects [21 CFR 56.108 (a)(4)].  In such a 
case, the IRB must be promptly informed of the change following its implementation (within 10 
working days) on Form 109 (www.etsu.edu/irb).  The IRB will review the change to determine that it 
is consistent  with  ensuring  the  subject’s  continued  welfare. 
 
Sincerely, 
George Youngberg, M.D., Chair 
ETSU/VA Medical IRB  
